9 Myalgic Encephalomyelitis Clinical Trials in Buffalo, NY (2026)

Q: How do I join a clinical trial in Buffalo?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Buffalo research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Buffalo

NCT04068649Recruiting

Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

This phase II trial studies how well single-fraction stereotactic body radiation therapy (SBRT) works when compared to standard radiation therapy in treating patients with cancer that has spread to ot...

Buffalo, NYPHASE21,500 participantsRoswell Park Cancer Institute

View Study Details

NCT05675735Recruiting

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Using a stepped-wedge randomized controlled trial, the study will test whether a clinic-level multidimensional intervention conducted in 36 opioid treatment programs (OTPs) will improve clinical decis...

Buffalo, NYNA318 participantsNYU Langone Health

View Study Details

NCT04787042Recruiting

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab \[Gazyva®\] pre-treatme...

Buffalo, NYPHASE1316 participantsSimcha IL-18, Inc.

View Study Details

NCT05960929Recruiting

InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS

The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give I...

Buffalo, NYPHASE3220 participantsONY

View Study Details

NCT06481592Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial cancer....

Buffalo, NYPHASE260 participantsIovance Biotherapeutics, Inc.

View Study Details

NCT06863402Recruiting

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

This phase II trial tests how well nemtabrutinib in combination with pembrolizumab works in treating patients with Richter transformation, diffuse large B-cell lymphoma subtype (RT-DLBCL). Nemtabrutin...

Buffalo, NYPHASE232 participantsRoswell Park Cancer Institute

View Study Details

NCT05359848Recruiting

A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy

Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternat...

Buffalo, NYNA30 participantsState University of New York at Buffalo

View Study Details

NCT05356182Recruiting

A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies

The main idea of this study is that a low protein diet may alter the environment surrounding the tumor, enhancing the body's immune response leading to greater anticancer effects of treatment. This st...

Buffalo, NYNA30 participantsState University of New York at Buffalo

View Study Details

NCT04348747Recruiting

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

This phase IIa trial studies how well dendritic cell vaccines against Her2/Her3 and pembrolizumab work for the treatment of triple negative breast cancer or HER2+ breast cancer or HER+ Breast cancer t...

Buffalo, NYPHASE223 participantsRoswell Park Cancer Institute

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Buffalo

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 9 myalgic encephalomyelitis clinical trials recruiting participants in Buffalo, NY. These studies are seeking a combined 2,529 participants. Research is being sponsored by Roswell Park Cancer Institute, NYU Langone Health, Simcha IL-18, Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Buffalo — FAQ

Are there myalgic encephalomyelitis clinical trials in Buffalo?

Yes, there are 9 myalgic encephalomyelitis clinical trials currently recruiting in Buffalo, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Buffalo?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buffalo research site will contact you about next steps.

Are clinical trials in Buffalo free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buffalo studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 9 active trials in Buffalo are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated September 1, 2026 from ClinicalTrials.gov